Dr Ching Chi Keong

Director of Cardiac Electrophysiology and Pacing, NHCS, Singapore

Dr Lars Wallentin

Prof of Cardiology, Uppsala University Hospital, Sweden

Home > Education & CME > Webinar > Novel Biomarker-based Risk Score in AF: ABC Risk Score

Novel Biomarker-based Risk Score in AF: ABC Risk Score

20 June 2020

KEY TAKEAWAYS

ABC risk scores have been well validated and calibrated with a good discriminative ability for risk stratification of stroke and bleeding in non-valvular AF patients
The ABC risk score offers a better risk prediction for death than clinical variables
ABC risk scores provides a new tool to tailor the intensity, duration and type of treatment for the patient with non-valvular AF

Atrial Fibrillation is associated with a 5-fold increased risk of stroke and thus stroke prevention is the fundamental part of management of Atrial Fibrillation (AF) patients. The choice of antithrombotic therapy for AF patients need to balance the risk of stroke against major bleeding.

Compared with non-Asians, the incidence of AF-related risks of stroke and bleeding in Asians is generally higher. By attending this webinar, you will have better knowledge and competence on:

The current situation and challenges of stroke prevention in Atrial Fibrillation in Asia Pacific region
The introduction of GDF-15 the strongest bleeding marker
The clinical utility and validation data of the novel ABC (Age, Biomarker, Clinical History) risk scores in stroke prevention as well as it’s performance

Updates from Leading Experts

STRONG-HF: Post-discharge Heart Failure Management and Implementation of GDMT Heart Failure Therapy

Prof Alexandre Mebazaa shares the key results and highlights from the STRONG-HF study that assessed the safety, tolerability of optimization of guideline directed medical therapy.

28 March 2023

Prof Alexandre Mebazaa

CANVAS study: NT-proBNP and CVD risk reduction

Can you give us a short description of the CANVAS program? The CANVAS program was a set of two trials, whose goal was to evaluate the role of an SGLT2...

1 July 2021

Dr James L Januzzi